newsfilter
← Latest News
GlobeNewswire·

Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the "PARADIGM Trial")

MINNEAPOLIS and BRISBANE, Australia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,